CIK 0001370053
- Non-accelerated filer
- Smaller reporting company
ANAPTYSBIO, INC
Sign in to watch- Ticker
- ANAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203828755
- Phone
- +1 858-362-6295
- Business address
- 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
- Former names
- ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $249,372
- in 1 filing, $249K under 10b5-1 plans
Net −$249,372. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 67 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-06 | Lizzul Paul F. Chief Medical Officer | Exercise or conversion | +6,145 | 12,672 | ||
| 2024-01-06 | Lizzul Paul F. Chief Medical Officer | Exercise or conversion · Restricted Stock Unit | −6,145 | 18,435 | ||
| 2024-01-06 | LOUMEAU ERIC J Chief Legal Officer | Exercise or conversion | +5,545 | 5,545 | ||
| 2024-01-06 | LOUMEAU ERIC J Chief Legal Officer | Exercise or conversion · Restricted Stock Unit | −5,545 | 16,635 | ||
| 2024-01-06 | MULROY DENNIS Chief Financial Officer | Exercise or conversion | +5,245 | 6,209 | ||
| 2024-01-06 | MULROY DENNIS Chief Financial Officer | Exercise or conversion · Restricted Stock Unit | −5,245 | 15,735 | ||
| 2024-01-06 | Faga Daniel CEO | Exercise or conversion | +17,850 | 904,893 | ||
| 2024-01-06 | Faga Daniel CEO | Exercise or conversion · Restricted Stock Unit | −17,850 | 53,550 | ||
| 2024-01-03 | Jain Rita Director | Grant or award · Stock Option (right to buy) | +16,510 | 16,510 | ||
| 2024-01-03 | Jain Rita Director | Grant or award · Restricted Stock Unit | +6,030 | 6,030 | ||
| 2024-01-03 | Lizzul Paul F. Chief Medical Officer | Grant or award · Stock Option (right to buy) | +115,540 | 115,540 | ||
| 2024-01-03 | Lizzul Paul F. Chief Medical Officer | Grant or award · Restricted Stock Unit | +42,220 | 42,220 | ||
| 2024-01-03 | Marquet Magda Director | Grant or award · Stock Option (right to buy) | +16,510 | 16,510 | ||
| 2024-01-03 | Marquet Magda Director | Grant or award · Restricted Stock Unit | +6,030 | 6,030 | ||
| 2024-01-03 | Schmid John P. Director | Grant or award · Stock Option (right to buy) | +16,510 | 16,510 | ||
| 2024-01-03 | Schmid John P. Director | Grant or award · Restricted Stock Unit | +6,030 | 6,030 | ||
| 2024-01-03 | Orwin John A Director | Grant or award · Stock Option (right to buy) | +16,510 | 16,510 | ||
| 2024-01-03 | Orwin John A Director | Grant or award · Restricted Stock Unit | +6,030 | 6,030 | ||
| 2024-01-03 | RENTON HOLLINGS Director | Grant or award · Stock Option (right to buy) | +16,510 | 16,510 | ||
| 2024-01-03 | RENTON HOLLINGS Director | Grant or award · Restricted Stock Unit | +6,030 | 6,030 |
Page 18 of 27 · 522 trades